3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
5
Thoracic
1
Plasma cell
1
Myeloid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Classical hematology
1
Conditions
Ovarian Neoplasms
4
Carcinoma, Ovarian Epithelial
3
Uterine Cervical Neoplasms
2
Testicular Germ Cell Tumor
2
Neuroblastoma
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Sezary Syndrome
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Optic Nerve Glioma
1
Interventions
Colposcopy
5
Polymerase Chain Reaction
4
Biopsy
4
Watchful Waiting
2
Vaginal Smears
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Histological Techniques
2
Cidofovir
2
human papillomavirus vaccine, TA
1
human papillomavirus vaccine, L1 type 16, 18
1
Zoledronic Acid
1
Tretinoin
1
Transurethral Resection of Prostate
1
Spectrum Analysis
1
Spectrometry, Fluorescence
1
Sodium Chloride
1
Robotic Surgical Procedures
1
Radiotherapy
1
Pregnancy Tests
1
Papanicolaou Test
1
Mindfulness-Based Stress Reduction
1
Microarray Analysis
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Gene Expression Profiling
1
Folic Acid
1
Fluorophotometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
Microarray Analysis
×
Gynecologic
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled